Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker OLMA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2026 | OLMA Olema Oncology, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 10, 2026 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 15, 2026 | OLMA Olema Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 13, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | OLMA Olema Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 10, 2026 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 23, 2026 | OLMA Olema Oncology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 26, 2026 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 26, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 21, 2026 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 21, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2026 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 1, 2026 | OLMA Olema Oncology, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 1, 2026 | OLMA Olema Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 29, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 29, 2026 | OLMA Olema Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 16, 2026 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 30, 2026 | OLMA Olema Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 12, 2026 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 19, 2025 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 18, 2025 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 10, 2025 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 20, 2025 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 20, 2025 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 2, 2025 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 2, 2025 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2025 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2025 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 13, 2025 | OLMA Olema Oncology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 18, 2025 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 5, 2025 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 10, 2025 | OLMA Olema Oncology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 10, 2024 | OLMA Olema Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 10, 2024 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 2, 2024 | OLMA Olema Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 2, 2024 | OLMA Olema Oncology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 2, 2024 | OLMA Olema Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 12, 2024 | OLMA Olema Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
43 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances